OtherCommentary
Elastomer Change Out - Justification for minimizing the removal of elastomers in order to prevent cross contamination in a multiproduct facility.
Michael Parks, Niamh O'Dwyer, Jeremy Bollinger, Alan Johnson, Brian Goss, Ned Wyman, Adeyma Arroyo, Joseph Wood and Derek Willison-Parry
PDA Journal of Pharmaceutical Science and Technology September 2017, pdajpst.2016.007484; DOI: https://doi.org/10.5731/pdajpst.2016.007484
Michael Parks
1 Pfizer;
Niamh O'Dwyer
1 Pfizer;
Jeremy Bollinger
2 Biogen;
Alan Johnson
3 Amgen;
Brian Goss
4 Eli Lilly;
Ned Wyman
5 AstraZeneca;
Adeyma Arroyo
6 Genetech Roche;
Joseph Wood
6 Genetech Roche;
Derek Willison-Parry
7 Biophorum
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 1
January/February 2025
Elastomer Change Out - Justification for minimizing the removal of elastomers in order to prevent cross contamination in a multiproduct facility.
Michael Parks, Niamh O'Dwyer, Jeremy Bollinger, Alan Johnson, Brian Goss, Ned Wyman, Adeyma Arroyo, Joseph Wood, Derek Willison-Parry
PDA Journal of Pharmaceutical Science and Technology Sep 2017, pdajpst.2016.007484; DOI: 10.5731/pdajpst.2016.007484
Elastomer Change Out - Justification for minimizing the removal of elastomers in order to prevent cross contamination in a multiproduct facility.
Michael Parks, Niamh O'Dwyer, Jeremy Bollinger, Alan Johnson, Brian Goss, Ned Wyman, Adeyma Arroyo, Joseph Wood, Derek Willison-Parry
PDA Journal of Pharmaceutical Science and Technology Sep 2017, pdajpst.2016.007484; DOI: 10.5731/pdajpst.2016.007484
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.